S. Hanselmann

发表

The impact of adding low-dose leucovorin to monthly 5-fluorouracil in advanced colorectal carcinoma: results of a phase III trial. Swiss Group for Clinical Cancer Research (SAKK).

R. Herrmann, A. Goldhirsch, M. Castiglione, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Capecitabine in hormone-resistant metastatic prostatic carcinoma – a phase II trial

C. Rochlitz, H. Schmid, M. Borner, 2004, British Journal of Cancer.

Original article Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma

M. Fey, M. Borner, G. Zulian, 2005 .

Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma. Swiss Group for Clinical Cancer Research (SAKK).

C. Hürny, B. Thürlimann, M. Fey, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Vinorelbine in androgen-independent metastatic prostatic carcinoma--a phase II study.

B. Thürlimann, H. Schmid, M. Borner, 2002, European journal of cancer.

Efficacy of rituximab and cladribine in patients with chronic lymphocytic leukemia and feasibility of stem cell mobilization: a prospective multicenter phase II trial (protocol SAKK 34/02)

M. Gregor, M. Bargetzi, D. Heim, 2010, Leukemia & lymphoma.

Effect of carboplatin on response and palliation in hormone-refractory prostate cancer

A. Goldhirsch, C. Hürny, J. Bernhard, 1998, Supportive Care in Cancer.

Immediate versus deferred hormonal treatment for patients with prostate cancer who are not suitable for curative local treatment: results of the randomized trial SAKK 08/88.

T. Gasser, U. Studer, G. Thalmann, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer.

R. Stupp, R. Herrmann, A. Goldhirsch, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I I S tudy o f C apecitabine a nd O xaliplatin i n F irst- and S econd-Line T reatment o f A dvanced o r M etastatic Colorectal C ancer

R. Stupp, R. Herrmann, A. Goldhirsch, 2002 .

A Phase II study of oral idarubicin as a treatment for metastatic hormone‐refractory prostate carcinoma with special focus on prostate specific antigen doubling time

M. Castiglione, H. Schmid, R. Morant, 1997 .

A phase II study of oral idarubicin as a treatment for metastatic hormone-refractory prostate carcinoma with special focus on prostate specific antigen doubling time. Swiss Group for Clinical Cancer Research, Berne, Switzerland.

M. Castiglione, J. Bernhard, H. Schmid, 1997, Cancer.